Health
Commonly-prescribed drug for IBD blunts COVID-19 vaccine response – News-Medical.Net
People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of COVID-19 vaccine, after…

People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of COVID-19 vaccine, after a large-scale study found many had poor antibody responses.
The research measured antibody responses after vaccination with the Pfizer/BioNTech or the Oxford/AstraZeneca COVID-19 vaccine in 865 people treated with infliximab, an anti-tumour necrosis factor (anti-TNF) biologic drug, prescribed to around two million people worldwide. Anti-TNF…
-
Noosa News23 hours ago
Bali traveller sparks urgent measles alert across Queensland
-
Noosa News23 hours ago
Queensland man sentenced to four years imprisonment after string of terror offences
-
Business23 hours ago
The best ASX ETFs for compounding wealth until 2040
-
Noosa News22 hours ago
Measles alert issued south of Brisbane after traveller tests positive